Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
Location: United States, North Carolina, Hillsborough
Member count: 1-10
Total raised: $35M
Founded date: 2018
Founders name: Jason Kralic; Eric Benner
Founders Related Locations: Jamaica, Durham; United States, Carolina; United States, North Carolina, Durham
Investors 2
| Date | Name | Website |
| - | MassChalle... | masschalle... |
| - | Xontogeny | xontogeny.... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.12.2022 | Series A | $35M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 19.12.2022 | Digital he... | HistoSonics raised $100M; Memo... | - | Steven Loe... | vator.tv/n... |
| 13.12.2022 | Tellus The... | Tellus Therapeutics, a Dhuram,... | USA | - | finsmes.co... |
| 24.10.2019 | MassChalle... | BOSTON, October 24, 2019 – Mas... | - | - | masschalle... |
| 02.10.2019 | MassChalle... | October 2, 2019, BOSTON – Mass... | - | - | masschalle... |
| - | Tellus The... | “Tellus Therapeutics – –”... | - | - | fastfounde... |